CCT036477 is a Wnt/β-catenin pathway inhibitor that blocks β-catenin-mediated transcription without altering its protein levels; it inhibits proliferation of various cancer cells, embryonic development, and expression of Wnt target genes (PPARδ, Cyclin D1, TCF4, and ID2).